| |
|
|
Il Sung Pharm. (003120) |
|
|
STOCK |
|
|
|
  |
(unit : Won, Share) |
| Fiscal Year End |
04.12 | 05.12 | 06.12 | 07.06 |
| Par Value |
5,000 | 5,000 | 5,000 | 5,000 |
| Yearly Highest Price |
24,700 | 65,700 | 85,900 | 135,500 |
| Yearly Lowest Price |
13,200 | 20,500 | 48,000 | 77,700 |
| Common Shares O/S |
2,660,000 | 2,660,000 | 2,660,000 | 2,660,000 |
| Preferred Shares O/S |
- | - | - | - |
| Market Cap.(100Mn.Won) |
657 | 1,303 | 2,258 | 2,872 |
| Dividends (%) |
8.0 | 8.0 | 10.0 | - |
|
 |
(Company/Sector/Market) |
| |
2006.06 | 2007.06 |
| Beta |
0.62 / 0.92 / 1.00 | 0.22 / 0.72 / 1.00 |
| Volatility |
42.54 / 30.84 / 19.70 | 32.56 / 19.70 / 14.26 |
|
 |
(unit : Won) |
| Fiscal Year End |
04.12 | 05.12 | 06.12 | 07.06 |
| Earnings Per Share |
5,385 | 10,586 | 14,485 | 7,962 |
| Sales Per Share |
26,873 | 29,014 | 29,545 | 31,225 |
| Book Value Per Share |
47,607 | 66,013 | 86,563 | 110,698 |
| Cash Flow Per Share |
7,503.83 | 6,684.92 | 4,470.45 | 778.87 |
|
 |
(Unit : Times) |
| Fiscal Year End |
04.12 | 05.12 | 06.12 | 07.06 |
| Price / Earnings (H/L) |
4.59/2.45 | 6.21/1.94 | 5.93/3.31 | 17.02/9.76 |
| Price / Sales (H/L) |
0.92/0.49 | 2.26/0.71 | 2.91/1.62 | 4.34/2.49 |
| Price / Book (H/L) |
0.52/0.28 | 1.00/0.31 | 0.99/0.55 | 1.22/0.70 |
| Price / Cash Flow (H/L) |
3.29 / 1.76 | 9.83 / 3.07 | 19.22 / 10.74 | 173.97 / 99.76 |
|
 |
(Unit : 100Mn.Won, %) |
| Fiscal Year End |
03.12 |
04.12 |
05.12 |
06.12 |
| Company |
Sector |
Company |
Sector |
Company |
Sector |
Company |
Sector |
| Invested Capital |
634 |
723 |
535 |
718 |
450 |
756 |
524 |
- |
| NOPLAT |
111 |
48 |
113 |
80 |
142 |
72 |
151 |
- |
| Return on Invested Capital |
17 |
6 |
21 |
11 |
31 |
9 |
28 |
- |
| WACC |
6 |
6 |
6 |
6 |
6 |
6 |
5 |
- |
| Economic Value Added |
67.5 |
2.5 |
80.7 |
37.5 |
110.8 |
23.1 |
121.0 |
- |
|
 |
(Unit : 100Mn.Won, Times) |
| Fiscal Year End |
2004.12 | 2005.12 | 2006.12 | 2007.03 |
| Enterprise Value(EV) |
657.02 | 1,303.40 | 2,258.34 | 2,407.30 |
| EBITDA |
183.29 | 217.99 | 228.56 | 230.27 |
| EBITDA/Sales |
0.26 | 0.28 | 0.29 | 0.29 |
| EBITDA/Financial Exp. |
16,263.80 | 6,957.88 | 622.13 | 469.22 |
| EV/EBITDA |
3.58 | 5.98 | 9.88 | 10.45 |
|
|
|
|
